Stocks and Investing
Stocks and Investing
Thu, January 2, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, December 31, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, December 30, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, December 27, 2019
[ 12:00 AM ] - WOPRAI
Thu, December 26, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Steve Scala Reiterated (ABBV) at Buy with Increased Target to $98 on, Dec 26th, 2019
Steve Scala of TD Cowen, Reiterated "AbbVie Inc." (ABBV) at Buy with Increased Target from $90 to $98 on, Dec 26th, 2019.
Steve has made no other calls on ABBV in the last 4 months.
There are 2 other peers that have a rating on ABBV. Out of the 2 peers that are also analyzing ABBV, 0 agree with Steve's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Steve
- Andrew Baum of "Citigroup" Maintained at Strong Buy with Increased Target to $98 on, Wednesday, November 20th, 2019
- Marc Goodman of "UBS" Maintained at Strong Buy with Increased Target to $96 on, Tuesday, November 19th, 2019